reference/4490377

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4490377

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
issn	1745-6215 1468-6708
issueIdentifier	1
pageRange	120-
publicationName	Trials
startingPage	120
bibliographicCitation	Tanaka S, Sakamori Y, Niimi M, Hazama M, Kim YH, Yanagihara K. Design paper: a phase II study of bevacizumab and erlotinib in patients with non-squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous treatment (BEST). Trials. 2011 May 12;12():120. PMID: 21569411; PMCID: PMC3113989.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c25758eaaec78f5a2fc77f4bee9a5057 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d5be745c9dbc7ef98a264843de47cf5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_775e2890ce6d1c3b45e35c2a43fdbbbf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e992d9a032c3ae83be23425efdd610bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cd776ef6fa5774f2d20cf4a06f3c979 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c33f9729a0a25327832bb59f8b0a999
date	2011-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1186/1745-6215-12-120 https://pubmed.ncbi.nlm.nih.gov/PMC3113989 https://pubmed.ncbi.nlm.nih.gov/21569411
isPartOf	https://portal.issn.org/resource/ISSN/1468-6708 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/26742 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32804 https://portal.issn.org/resource/ISSN/1745-6215
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Design paper: A phase II study of Bevacizumab and Erlotinib in patients with non-Squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous Treatment (BEST)
discusses	http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0493669 http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0328153 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0443627 http://id.nlm.nih.gov/mesh/M0500817
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D009364 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D012107
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D002289Q000401 http://id.nlm.nih.gov/mesh/D008175Q000235 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D008175Q000401 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D066246Q000235 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D002289Q000235 http://id.nlm.nih.gov/mesh/D016879 http://id.nlm.nih.gov/mesh/D011799Q000008 http://id.nlm.nih.gov/mesh/D020533Q000008 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D047428Q000008 http://id.nlm.nih.gov/mesh/D007564 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D066246Q000037 http://id.nlm.nih.gov/mesh/D000069347 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D000068258 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168

Incoming Links

Predicate

Subject

http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127377427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128090325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136123131

Total number of triples: 80.